Market access update
How to identify the potential for commercial success in early-stage product development
In early-phase value-driven development, it’s never too early to start thinking about commercial success. The PRMA Healthcheck® digital application will help you develop your strategic rationales at this critical .
The PRMA Healthcheck® assessments of early-phase assets help you to identify the potential for commercial success and shape direction and strategy at the earliest stages of product development.
This case study from a leading pharmaceutical manufacturer explains how the digital application helped the organization to:
- focus thinking on early-phase value-driven development
- promote discussion across the clinical development, commercialization, and market access teams
- manage early portfolios by making sequencing decisions and prioritizing high potential indications and assets
- estimate the long-term value or commercial potential of its assets to reduce the uncertainty associated with early development.
Maximize the pricing and market access potential of your early pipeline